Stoke Therapeutics, Inc. STOK Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$50M+13.7% | -$57.93M-51.1% | -$38.35M-63.3% | -$23.48M-121% | $112.88M+1,177% | ||
| $439K+8.4% | $405K-8.4% | $442K-0.9% | $446K-6.5% | $477K-9.3% | ||
| $8.75M-11.1% | $9.85M+22.5% | $8.04M+5.8% | $7.6M+12.5% | $6.75M-5.4% | ||
| -$60.58M— | —— | —— | —— | $131.83M+668% | ||
| $353K+52.2% | $232K+75.8% | $132K-14.3% | $154K+1.3% | $152K+262% | ||
| $50.69M+183% | -$61.06M— | $0+100% | -$148.48M-1,189% | $13.63M— | ||
| $84.33M-8.7% | $92.34M+2,860% | $3.12M+463% | $554K-59.7% | $1.37M+142% | ||
| $74.44M— | $0+100% | -$18.15M+89.5% | -$173.35M-218% | $146.83M+773% | ||
| -$60.94M— | —— | —— | —— | $131.68M+667% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Stoke Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Stoke Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.